|
|
||||||||
Departments of 1 Pharmacology and Toxicology, 3 Surgery, 4 Medicine (Institute for Molecular Medicine and Genetics), and 5 Cell Biology and Anatomy and the 2 Vascular Biology Center, Medical College of Georgia, Augusta 30912; and the 6 Augusta Veterans Administration Medical Center, Augusta, Georgia 30910
| |
ABSTRACT |
|---|
|
|
|---|
Cyclic nucleotide-dependent vascular relaxation is associated with increases in the phosphorylation of a small heat shock protein (HSP), HSP20. An increase in phosphorylation of another small HSP, HSP27, is associated with impaired cyclic nucleotide-dependent vascular relaxation. Expression of HSPs is altered by exposure to several types of cellular stress in vitro. To determine if behavioral stress in vivo alters vascular expression and phosphorylation of the small HSPs and cyclic nucleotide-dependent vascular relaxation, borderline hypertensive rats were stressed by restraint and exposure to air-jet stress 2 h/day for 10 days or remained in their home cage. Stress impaired relaxation of aorta to forskolin, which activates adenylyl cyclase, and sodium nitroprusside, which activates guanylyl cyclase. This was associated with an increase in the aortic expression and phosphorylation of HSP27, which was localized to the vascular smooth muscle, but a decrease in the amount of phosphorylated (P)-HSP20. To determine if P-HSP27 inhibits phosphorylation of HSP20, P-HSP27 was added to a reaction mixture containing recombinant HSP20 and the catalytic subunit of cAMP-dependent protein kinase. P-HSP27 inhibited phosphorylation of HSP20 in a concentration-dependent manner. These data demonstrate that P-HSP27 can inhibit phosphorylation of HSP20. The increase in P-HSP27 and decrease in P-HSP20 were associated with reduced cyclic nucleotide-dependent vascular smooth muscle relaxation in response to behavioral stress in vivo, an effect similar to that observed previously in response to cellular stress in vitro.
behavioral stress; vascular smooth muscle; hypertension
| |
INTRODUCTION |
|---|
|
|
|---|
EXPOSURE OF ORGANISMS TO STRESS leads to activation of the hypothalamic-pituitary-adrenal axis with the production and release of catecholamines. On a cellular level, stress is associated with the induction of a group of proteins termed heat shock proteins (HSPs). The heat shock response was first described in Drosophila in which exposure to temperatures above normal led to an increase in the expression of HSPs (23). Subsequently, it has been determined that expression of HSPs can be elicited by a number of factors besides heat, such as circulating catecholamines, heavy metals, arsenite, hypoxia, free radicals, and osmotic stress (for review, see Ref. 3).
HSPs are divided into five major families on the basis of molecular weight and function. Although the precise functions of the HSPs are not known, many HSPs act as "molecular chaperones" and assist in the assembly, disassembly, stabilization, and internal transport of intracellular proteins. Cells stressed by a mild insult are more resistant to a subsequent stress, and this response termed stress tolerance is mediated by HSPs (3). Thus the induction of stress proteins protects the organism from repeated stresses and has been shown to protect the ischemic heart (21).
The small HSPs (molecular mass 20-30 kDa) may have a role in the regulation of smooth muscle tone. HSP27 and HSP20 are highly and constituitively expressed in muscle tissues (17). Increases in the phosphorylation of HSP27 have been associated with smooth muscle contraction (10, 19). Antibodies against HSP27 inhibit bombesin-induced contraction of rectal sphincter smooth muscle (5). Increases in the phosphorylation of HSP20 are associated with cyclic nucleotide-dependent relaxation of vascular smooth muscle and cyclic nucleotide-dependent inhibition of agonist-induced contraction (2, 30). Increases in phosphorylation of HSP20 are also associated with endothelium-dependent vasodilation (15). The addition of phosphopeptide analogs of HSP20 into transiently permeabilized vascular smooth muscle attenuates agonist-induced contraction (1). HSP20 was first identified as a by-product of the purification of HSP27, and the two small HSPs coexist in macromolecular aggregates (8, 17). Thus HSP27 and HSP20 may have interrelated roles in modulating the tone of smooth muscle, and the function of these proteins may be dependent on the phosphorylation state and macromolecular associations of the proteins.
Behavioral stress is associated with several vascular diseases including hypertension, atherosclerosis, and coronary artery disease (16, 24, 25). The borderline hypertensive rat (BHR), a first generation offspring of a female spontaneously hypertensive rat (SHR) and male Wistar Kyoto (WKY) rat, has been used extensively for studies on behavioral stress due to its sensitivity to several environmental challenges (26). Prolonged exposure of BHR to behavioral stress results in sustained hypertension that persists after removal of the stress (26). We have demonstrated that chronic behavioral stress (10 days) alters vascular contraction and relaxation in adult BHR (11, 12). These stress-induced alterations in vascular relaxation could contribute to pathogenesis of hypertension. Because HSPs are known modulators of vascular tone and are induced by several types of stress in vitro, the present study was designed to determine if exposure of BHR to behavioral stress in vivo alters vascular smooth muscle cyclic nucleotide-dependent relaxation and expression and phosphorylation of the small HSPs, HSP20 and HSP27.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Air-jet stress in BHR. Female SHR and male WKY rats were obtained from Taconic Farms (Germantown, NY) and bred at the Medical College of Georgia to obtain the first generation offspring BHR. Male BHR (13-14 wk) were randomly divided into two groups (control or stressed). The stressed group was restrained in tubular Plexiglas restrainers and exposed to air-jet stress for 2 h/day for 10 days, whereas the control group remained in their home cage for 10 days. Air-jet stress consisted of pulses of compressed air (15 lb./in.2) directed toward the face from an 1/8-in. opening at the front of the restrainer. Animals were subjected to a random duration of pulses (5 to 120 s) and interpulse intervals (5 to 120 s) 2 h/day for 10 days.
Hemodynamic measurements. On day 10, both stressed and unstressed rats were anesthetized with ketamine (50 mg/kg im) and acepromazine (16 mg/kg im). Under aseptic conditions, a cannula (PE-50 attached to PE-10) was placed in the femoral artery and exteriorized at the nape of the neck. The cannula was flushed with heparinized saline (100 U/ml). After a 1-day recovery period, arterial pressure and heart rate were monitored with a Grass recorder in unrestrained rats in their home cage. Heart rate was derived with a cardiotachometer that was triggered from the arterial pressure pulse.
Vascular reactivity. On day 11, rats were anesthetized with pentobarbital sodium (50 mg/kg ip). The aorta was dissected and placed directly in cold HEPES buffer [(in mM) 140 NaCl, 4.7 KCl, 1.0 MgSO4, 1.0 NaH2PO4, 1.5 CaCl2, 10 glucose, and 10 HEPES, pH 7.4]. The endothelium was denuded mechanically by gently rubbing the luminal surface with forceps. This procedure results in complete removal of the endothelium, as verified previously with scanning electron microscopy and by the absence of relaxation to the endothelium-dependent vasodilator acetylcholine without affecting relaxation to the endothelium-independent vasodilator nitroprusside (15, 31). A portion of aorta was used for immunoblotting or immunofluorescence, whereas the remainder was used for vascular reactivity experiments.
Transverse rings, 1.0 mm in width, were cut, and each end was tied to a loop of 3-0 silk. The tissue was suspended in a muscle bath containing bicarbonate buffer [(in mM) 120 NaCl, 4.7 KCl, 1.0 MgSO4, 1.0 NaH2PO4, 10 glucose, 1.5 CaCl2, and 25 Na2HCO3, pH 7.4], equilibrated with 95% O2/5% CO2 at 37°C. The rings were fixed at one end to a stainless steel wire and attached to a Kent Scientific (Litchfield, CT) force transducer (TRN001) interfaced with a Data Translation A-D board, DT2801 (Data Translation, Marlboro, MA). Data was acquired with Daisylab software (Daisytec, Amherst, NH). Agonists were added directly to the bath, and the concentrations indicated represent the final concentration of the agonist. Vascular rings were progressively stretched, and isometric force generated in response to 110 mM KCl was monitored until optimal tension was produced (Lmax). After washing and equilibration for at least 30 min, vessels were precontracted with serotonin (10
6 M) for 15 min followed by the addition of
either sodium nitroprusside (10
6 M) or forskolin
(10
6 M). After each experiment, tissues were blotted and
the wet weight was measured. Force was converted to stress
(105 N/m2), calculated as force (g) × 0.0987/area, where area = wet weight (mg)/length (mm at
Lmax)/1.055. The maximal relaxation response, which
occurred within 10 min after sodium nitroprusside or forskolin treatment, was calculated as a percentage of the contractile response to serotonin.
Immunoblotting.
Aortas were snap-frozen in liquid nitrogen and ground to a fine powder
with a mortar and pestle, and proteins were precipitated in 90%
acetone, 10% trichloroacetic acid, and 10 mM dithiothreitol. The
samples were centrifuged at 10,000 g, and the precipitated proteins were washed three times with acetone to remove the
trichloroacetic acid. The proteins were then solublized in 6 M urea,
2% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), and 10 mM dithiothreitol overnight at room temperature. The
samples were centrifuged at 10,000 g, and the protein
concentration of the supernatant was determined with a Pierce Coomassie
Protein Assay Kit (Rockville, IL). Sample buffer (250 mM Tris, pH 6.8; 2% glycerol, 10 mM
-mercaptoethanol, 2 mM EGTA, 4% SDS, 0.001% bromphenol blue) was added (1:1 dilution), and 30 µg of protein was
separated on 15% SDS-PAGE gels and transferred to Immobilon for 210 V/h. The blots were air-dried and subsequently blocked with
Tris-buffered saline (TBS; 10 mM Tris, 150 mM NaCl, pH 7.4)/5% milk
for 1 h. The blots were then incubated with anti-HSP27 antibodies (1:10,000 dilution), phosphorylation state-specific HSP27 antibodies (1:500 dilution), anti-HSP20 antibodies (1:2,000 dilution),
phosphorylation state-specific HSP20 antibodies (1:100 dilution), and
anti-inducible HSP70 (1:1,000 dilution) in TBS/milk overnight at 4°C.
The blots were washed three times (5 min each) in
TBS/polyoxyethylenesorbitan monolaurate (Tween 20) (0.5%).
Immunoreactive protein was determined with the use of
125I-protein A or enhanced chemiluminescence (DuPont NEN,
Boston, MA). The blots were again washed six times (5 min each) in
TBS/Tween 20 and exposed on PhosphorImager screens (Molecular Dynamics, Sunnyvale, CA) or X-ray film.
Immunofluorescence. Segments of rat aorta were fixed in 4% Formalin and embedded in paraffin. Six-micrometer cross sections were mounted on polylysine slides. The slides were deparaffinized with xylene and graded dilutions of ethanol. The sections were rinsed in PBS (10 mM phosphate, pH 7.5; 0.15 M NaCl) and incubated with anti-HSP27 antibodies (1:100 dilution) or phosphorylation state-specific HSP27 antibodies (1:100 dilution) for 12 h at 4°C. The sections were rinsed in PBS and incubated with Cy-3 conjugated donkey anti-mouse or goat anti-rabbit secondary antibodies (1:100 dilution) for 1 h at room temperature, rinsed again in PBS, and mounted with ProLong Antifade Kit (Molecular Probes, Eugene, OR). The slides were viewed with a Zeiss Axiophot microsocope interfaced with a digital Spot camera.
Cloning and expression of HSP20. For experiments determining the effect of phosphorylated (P)-HSP27 on phorphorylation of HSP20, recombinant HSP27 and recombinant HSP20 were used. Recombinant HSP27 was purchased from StressGen. The rat cDNA for HSP20 was PCR amplified with the use of sense (GAA TTC ATA TGG AGA TCC GGG TGC CTG TGC) and antisense (CGT ACT CGA GCT ACT TGG CAG CAG GTG GTG ACT) primers (synthesized by Gibco BRL, Grand Island, NY). The PCR products were ligated into PCR-script SK (+) cloning vector and ultimately transformed into BL21(DE3)pLysS cells (Promega, Madison, WI), as previously described (9). The HSP20 was affinity purified with the use of a HIS-bind resin column (Novagen, Madison, WI). Proteins from the fractions were separated on SDS-PAGE gels, and fractions containing a single band at 20 kDa were dialyzed against PBS/1% CHAPS.
In vitro phosphorylation of HSP20 and HSP27.
Phosphorylation of HSP27 was accomplished by adding recombinant HSP27
(20 µg) to a reaction mixture with 0.25 U MAPKAP kinase II in 20 mM
MOPS, pH 7.2, 25 mM
-glycerol phosphate, 5 mM EGTA, 1 mM
sodium orthovanadate, and 1 mM dithiothreitol. The
reaction was started with the addition of 200 µM ATP and stopped by
separating the kinase from HSP27 with molecular sieving columns
(Centricon 40, Amicon, Beverly, MA).
-[32P]ATP (800 counts · min
1 · pmol
1)
followed by incubation for 30 min at 30°C. The reaction was stopped
by the addition of 6.25 mM Tris (pH 6.8), 2% SDS, 5%
2-mercaptoethanol, 10% glycerol, and 0.025% bromphenol blue and
boiling for 5 min (1:1, vol/vol). The proteins were separated on 15%
SDS-PAGE gels, and an autoradiogram was obtained.
Chemicals.
HEPES and CHAPS were obtained from American Bioanalytical (Natick, MA).
SDS, glycine, and Tris were from Research Organics (Cleveland, OH).
125I-protein A and 125I-protein were from
Amersham (Arlington Heights, IL). Forskolin was from Calbiochem (La
Jolla, CA). Piperazine diacrylamide and other electrophoresis reagents
were from Bio-Rad (Hercules, CA). Sodium nitroprusside, serotonin,
EGTA, EDTA, Tween 20,
-actin antibodies, and all other reagent grade
chemicals were from Sigma (St. Louis, MO). Antibodies against HSP27
were from Dr. Michael Welsh (Ann Arbor, MI) (29) and those
against HSP20 were from Dr. Kanefusa Kato (Aichi, Japan)
(17). Phosphorylation state-specific anti-HSP20 and
anti-HSP27 antibodies were produced and characterized as previously
described (1, 18). Antibodies against the
inducible form of HSP70 (iHSP70),
-[32P]ATP,
125I-protein A, 125I-IgG were from Amersham.
Anti-mouse and anti-rabbit secondary antibodies were from Jackson
Immunochemical (West Grove, PA). The catalytic subunit of
cAMP-dependent PKA was purchased from Promega. MAPKAP kinase II was
purchased from Upstate Biotechnology (Lake Placid, NY). Recombinant
HSP27 was from StressGen (Victoria, BC, Canada).
Data analysis. Values are reported as means ± SE and n refers to the number of animals examined. The statistical difference between two groups was determined with Student's t-test and between multiple groups with one-way, repeated-measures ANOVA with the use of Sigma Stat software (Jandel Scientific, San Rafeal, CA). A P value <0.05 was considered significant. Densitometric analysis was performed on immunoblots in which 125I-protein A (for rabbit primary antibodies) or 125I-IgG (for mouse primary antibodies) was used as the secondary antibody with a PhosphorImager (Molecular Dynamics) and ImageQuant software (Molecular Dynamics).
| |
RESULTS |
|---|
|
|
|---|
Hemodynamic measurements. Hemodynamic measurements were obtained from conscious, unrestrained BHR after 10 days of stress (stressed group, n = 10) or after 10 days in their home cage (control group, n = 9). Resting mean arterial pressure was 125 ± 3 mmHg in control BHR and 126 ± 4 mmHg in stressed BHR, and heart rate was 340 ± 15 beats/min in control BHR and 328 ± 12 beats/min in stressed BHR. Therefore, chronic stress did not significantly alter resting mean arterial pressure or heart rate in BHR.
Vascular reactivity.
There were no significant differences in the magnitude of the
contractile response to KCl (110 mM; Fig.
1A) or serotonin
(10
6 M; Fig. 1B) in aortic smooth muscle from
stressed compared with control BHR. To determine if air-jet stress led
to alterations in smooth muscle relaxation responses, aortic smooth
muscle was precontracted with serotonin (10
6 M), and the
magnitude of relaxation in response to sodium nitroprusside (10
6 M) or to forskolin (10
6 M) was
determined. These doses of sodium nitroprusside and forskolin led to
complete relaxation of control aortic smooth muscle. However, in aortic
smooth muscle from air-jet stressed BHR, the magnitude of the
relaxation response to both sodium nitroprusside (Fig. 2A) and forskolin (Fig.
2B) was significantly less than from smooth muscle obtained
from control animals.
|
|
HSP expression and phosphorylation.
Behavioral stress has been shown to increase expression of iHSP70, an
indication of a stress response (28). To determine if
stress led to induction of HSP70 in our model, immunoblotting was
performed with the use of antibodies that recognize iHSP70. There were
significant increases in the amount of immunoreactive iHSP70 in aorta
from stressed compared with control BHR (Fig. 3).
|
-actin. There were no
differences in the amounts of immunoreactive
-actin between the
aorta from stressed and control BHR (10.2 ± 0.9 vs. 11.4 ± 1.2 relative densitometric units, respectively, P > 0.05, n = 6).
|
|
Immunolocalization of HSP27.
To determine the localization of HSP27, immunofluorescence studies were
performed on Formalin-fixed, paraffin-embedded aortas from stressed and
control BHR. Exposure to stress increased aortic immunofluorescent
staining for HSP27. The staining pattern indicated that the
immunoreactive HSP27 was diffusely cytoplasmic in the medial smooth
muscle cells of the aortic wall (Fig. 6).
Stress also increased immunofluorescent staining for P-HSP27. The
immunoreactive P-HSP27 was localized to smooth muscle cells at the
adventitial ( A) and lumenal ( L) aspect of
the media. The only fluorescence detected when the primary antibody was
ommitted or when mouse ascitic fluid or nonspecific rat serum was used
as a primary antibody was the elastic lamella, which autofluoresced
(data not shown). The antibodies used for HSP20 and for P-HSP20 did not
produce consistent or specific staining in Formalin-fixed tissues.
|
Effect of P-HSP27 on phosphorylation of HSP20.
Our findings demonstrate that stress increases P-HSP27 and decreases
P-HSP20. Previous studies (7, 18,
30) suggest that stress-induced increases in P-HSP27 leads
to impaired phosphorylation of HSP20. All of these conditions are
associated with impaired cyclic nucleotide-dependent relaxation. The
following experiment was designed to determine if P-HSP27 could inhibit
HSP20 phosphorylation in vitro. Recombinant HSP27 was phosphorylated by
MAPKAP kinase II, and the MAPKAP kinase II was removed with molecular
sieving columns. Increasing concentrations of nonphosphorylated HSP27 or P-HSP27 were then added to a reaction mixture containing recombinant HSP20 and the catalytic subunit of PKA. Nonphosphorylated HSP27 had no
effect on phosphorylation of HSP20 (Fig.
7A). P-HSP27 inhibited the
phosphorylation of HSP20 in a concentration-dependent and linear
(r2 = 0.982) fashion (Fig. 7B).
P-HSP27 did not inhibit the phosphorylation of another PKA substrate,
KEMPtide (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
BHR have been used extensively for studies on behavioral stress because they are sensitive to several environmental challenges (26). Prolonged exposure of BHR to behavioral stress results in sustained hypertension that persists after removal of the stress (26). However, as we observed previously (11, 12), exposure to only 10 days of air-jet stress did not alter the resting arterial pressure of conscious BHR in this study, allowing for determination of behavioral stress-induced changes in aortic vascular reactivity and HSP expression and phosphorylation before development of hypertension. In the present study, stress impaired relaxation of aortic smooth muscle to two substances that activate cyclic nucleotide-dependent signaling pathways, forskolin, which activates adenylyl cyclase, and sodium nitroprusside, which activates guanylyl cyclase. This decreased ability of the vascular smooth muscle to relax, which could contribute to development of stress-induced hypertension, was associated with an increase in expression of the phosphorylated isoform of HSP27 and a decrease in expression of the phosphorylated isoform of HSP20. These effects may be due to restraint, air-jet stress, or a combination of both stressors.
There is increasing evidence of a role for HSPs in vascular diseases such as hypertension. Hypertension induced by stress leads to increased expression of the stress-inducible form of HSP70 in vascular and adrenal tissue (28). Another large HSP, HSP90, modulates the function of nitric oxide synthase. Increased nitric oxide production in the mesenteric vasculature of portal hypertensive rats was mediated by HSP90 (27). Currently, the role of the small HSPs, HSP20 and HSP27, in hypertension is unknown. However, the small HSPs have been implicated in regulation of vasomotor tone.
Increases in the phosphorylation of HSP20 are associated with cyclic nucleotide- and endothelium-dependent vascular relaxation (2, 15). Phosphorylation of HSP27 is associated with impaired cyclic nucleotide-dependent relaxation (18). Additional data demonstrating an association between the phosphorylation of the small HSPs and smooth muscle tone include the finding that umbilical artery smooth muscle contains high levels of HSP27 and P-HSP27 and is uniquely refractory to cyclic nucleotide-dependent relaxation (4, 7, 20, 22). In umbilical artery, activation of cyclic nucleotide-dependent signaling pathways with forskolin does not increase phosphorylation of HSP20 (30). Finally, the addition of phosphopeptide analogs of HSP20 into transiently permeabilized vascular smooth muscle inhibits agonist-induced contractions (1). The findings of the present study provide additional evidence that small HSPs modulate vascular tone. The stress-induced increase in phosphorylation of HSP27 and decrease in the amount of the phosphorylated isoform of HSP20 in aortic medial smooth muscle were associated with impaired cyclic nucleotide-dependent relaxation.
HSP20 and HSP27 share considerable sequence homology and appear to be biochemically associated in muscle tissues (8, 17). The decreased phosphorylation of HSP20 observed in aorta from stressed BHR in the present study, in umbilical smooth muscle (30), and in bovine carotid artery smooth muscle treated with arsenite (18) in previous studies may be due to a direct inhibition of the phosphorylation of HSP20 by P-HSP27. Our studies on the effect of phosphorylated recombinant HSP27 on the phosphorylation of recombinant HSP20 by PKA in vitro support this hypothesis. HSP27 that was phosphorylated in vitro by MAPKAP kinase II inhibited PKA-induced phosphorylation of HSP20 in a concentration-dependent manner. However, P-HSP27 did not inhibit the phosphorylation of another PKA substrate, KEMPtide, showing that P-HSP27 is not a direct inhibitor of PKA.
The mechanism by which HSP20 and HSP27 modulate vascular tone is unknown. Our studies suggest that the functions of HSP20 and HSP27 may be dependent on macromolecular associations with each other and the phosphorylation state of the HSPs. HSP20 and HSP27 can also interact with specific elements of the contractile machinery (8, 9, 17). HSP27 is an actin-binding protein and modulates actin filament dynamics (13). HSP27 has also been associated with thin filament regulatory proteins such as tropomyosin, caldesmon, and calponin (14). HSP20 binds to actin in vitro, and the association with actin is dependent on the phosphorylation state of HSP20 (9). Thus the small HSPs, HSP27 and HSP20, may modulate smooth muscle tone by interacting with specific elements of the contractile machinery, such as the thin filament actin and/or thin filament regulatory proteins, and by modulating the function of these proteins.
In conclusion, behavioral stress led to increases in the expression and phosphorylation of HSP27 and decreases in the amount of P-HSP20 in BHR aortic smooth muscle. These alterations in small HSP expression and phosphorylation were associated with impaired cyclic nucleotide-dependent relaxation of vascular smooth muscle. Finally, P-HSP27 inhibited the ability of PKA to phosphorylate HSP20 in vitro. These findings demonstrate that P-HSP27 can inhibit phosphorylation of HSP20. Additionally, the decrease in phosphorylation of HSP20 was associated with reduced cyclic nucleotide-dependent vascular smooth muscle relaxation in response to behavioral stress, an effect similar to that observed previously in response to cellular stress (18).
Perspectives
The data in this manuscript provide a molecular mechanism through which behavioral stress-induced increases in the amount and phosphorylation of HSP27 lead to impaired vascular relaxation. This mechanism involves inhibition of phosphorylation of HSP20 that appears to contribute to cyclic nucleotide-dependent relaxation. Although the current data are primarily correlative, it provides a potential molecular mechanism for impaired cyclic nucleotide-dependent relaxation. In addition, our data demonstrate that P-HSP27 can directly impair the phosphoylation of HSP20, supporting the hypothesis that a stochiometric relationship between the amounts of P-HSP20 and HSP27 may regulate the tone of vascular smooth muscle. These data are consistent with findings in human tissue (umbilical artery smooth muscle) and in another animal model (bovine carotid artery smooth muscle) ex vivo. Thus we believe these data provide a compelling molecular connection between stress and altered vascular smooth muscle responses.| |
ACKNOWLEDGEMENTS |
|---|
These experiments were supported in part by National Institutes of Health (NIH) Grant R29-HL-49924 to L. Fuchs and by a Veterans Administration Merit Review Award and NIH Grant RO1-HL-58027-01 to C. Brophy.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: L. C. Fuchs, Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912 (E-mail: lfuchs{at}mail.mcg.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Received 11 January 2000; accepted in final form 7 March 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Beall, AC,
Bagwell CA,
Woodrum D,
Stoming T,
Kato K,
Suzuki A,
Rasmussen H,
and
Brophy CM.
Heat shock-related protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation.
J Biol Chem
274:
11344-11351,
1999
2.
Beall, AC,
Kato K,
Goldenring JR,
Rasmussen H,
and
Brophy CM.
Cyclic nucleotide-dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein.
J Biol Chem
272:
11283-11287,
1997
3.
Benjamin, IJ,
and
McMillan DR.
Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease.
Circ Res
83:
117-132,
1998
4.
Berg, C,
Brophy CM,
Dransfield D,
Lincoln TM,
Goldenring J,
and
Rasmussen H.
Impaired cyclic nucleotide-dependent relaxation in human umbilical artery smooth muscle.
Am J Physiol Heart Circ Physiol
268:
H202-H212,
1995
5.
Bitar, KN,
Kaminski MS,
Hailat N,
Cease KB,
and
Strahler JR.
HSP27 is a mediator of sustained smooth muscle contraction in response to bombesin.
Biochem Biophys Res Commun
181:
1192-1200,
1991[Web of Science][Medline].
6.
Breschi, MC,
Scatizzi R,
Martinotti E,
Pellegrini A,
Soldani P,
and
Paparelli A.
Morphofunctional changes in the noradrengergic innervation of the rat cardiovascular system after varying duration of noise stress.
Int J Neurosci
75:
73-81,
1994[Medline].
7.
Brophy, CM,
Beall A,
Mannes K,
Lamb S,
Dickinson M,
Woodrum D,
and
DeVoe LD.
Heat shock protein expression in umbilical artery smooth muscle.
J Reprod Fertil
114:
351-355,
1998
8.
Brophy, CM,
Dickinson M,
and
Woodrum D.
Phosphorylation of the small heat shock-related protein, HSP20, in vascular smooth muscles is associated with changes in the macromolecular associations of HSP20.
J Biol Chem
274:
6324-6329,
1999
9.
Brophy, CM,
Lamb S,
and
Graham A.
The small heat shock-related protein-20 is an actin-associated protein.
J Vasc Surg
29:
326-333,
1999[Web of Science][Medline].
10.
Brophy, CM,
Woodrum D,
Dickinson M,
and
Beall A.
Thrombin activates MAPKAP2 kinase in vascular smooth muscle.
J Vasc Surg
27:
963-969,
1998[Web of Science][Medline].
11.
Fuchs, LC,
Hoque AM,
and
Clarke NL.
Vascular and hemodynamic effects of behavioral stress in borderline hypertensive and Wistar-Kyoto rats.
Am J Physiol Regulatory Integrative Comp Physiol
274:
R375-R382,
1998
12.
Giulumian, AD,
Clark SG,
and
Fuchs LC.
Effect of behavioral stress on coronary artery relaxation altered with aging in BHR.
Am J Physiol Regulatory Integrative Comp Physiol
276:
R435-R440,
1999
13.
Guay, J,
Lambert H,
Gingras-Breton G,
Lavoie JN,
Huot J,
and
Landry J.
Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27.
J Cell Sci
110:
357-368,
1997[Abstract].
14.
Ibitayo, AI,
Sladick J,
Tuteja S,
Louis-Jacques O,
Yamada H,
Groblewski G,
Welsh MM,
and
Bitar KN.
HSP27 in signal transduction and association with contractile proteins in smooth muscle cells.
Am J Physiol Regulatory Integrative Comp Physiol
279:
R445-R454,
2000.
15.
Jerius, H,
Karolyi DR,
Mondy JS,
Beall A,
Wootton D,
Ku D,
Cable S,
and
Brophy CM.
Endothelial-dependent vasodilation is associated with increases in the phosphorylation of a small heat shock protein (HSP20).
J Vasc Surg
29:
678-684,
1999[Web of Science][Medline].
16.
Kamarck, TW,
Everson SA,
Kaplan GA,
Manuck SB,
Jennings R,
Salonen R,
and
Salonen JT.
Exaggerated blood pressure responses during mental stress are associated with enhanced carotid atherosclerosis in middle-aged Finnish men: findings from the Kuopio ischemic heart disease study.
Circulation
96:
3842-3848,
1997
17.
Kato, K,
Goto G,
Inaguma Y,
Hasegawa K,
Morishita R,
and
Asano T.
Purification and characterization of a 20-kDa protein that is highly homologous to alphaB-crystallin.
J Biol Chem
269:
15302-15309,
1994
18.
Knoepp, L,
Woodrum D,
Beall A,
Mondy JS,
and
Brophy CM.
Cellular stress inhibits vascular smooth muscle relaxation.
J Vasc Surg
31:
343-353,
2000[Web of Science][Medline].
19.
Larsen, JK,
Yamboliev IA,
Weber LA,
and
Gerthoffer WT.
Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle.
Am J Physiol Lung Cell Mol Physiol
273:
L930-L940,
1997
20.
Li, D,
Gordon CB,
Stagg CA,
and
Udelsman R.
Heat shock protein expression in human placenta and umbilical cord.
Shock
5:
320-323,
1996[Web of Science][Medline].
21.
Marber, MS,
Mestril R,
Chi SH,
Sayen MR,
Yellon DM,
and
Dillman WH.
Overexpression of the rat inducible 70-kDa heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.
J Clin Invest
95:
1446-1456,
1995.
22.
Renowden, S,
Edwards DH,
and
Griffith TM.
Impaired cyclic nucleotide-mediated vasorelaxation may contribute to closure of the human umbilical artery after birth.
Br J Pharmacol
106:
348-353,
1992[Web of Science][Medline].
23.
Ritossa, F.
Discovery of the heat shock response.
Cell Stress Chaperones
1:
97-98,
1996[Web of Science][Medline].
24.
Rozanski, A,
Blumenthal JA,
and
Kaplan J.
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
Circulation
99:
2192-2217,
1999
25.
Sanders, BJ,
Knardahl S,
and
Johnson AK.
Lesions of the anteroventral third ventricle (AV3V) and development of stress-induced hypertension in the borderline hypertensive rat.
Hypertension
13:
817-821,
1989
26.
Sanders, BJ,
and
Lawler JE.
The borderline hypertensive rat (BHR) as a model for environmentally induced hypertension: a review and update.
Neurosci Biobehav Rev
16:
207-217,
1992[Web of Science][Medline].
27.
Shah, V,
Wiest R,
Garcia-Cardena G,
Cadelina G,
Groszmann RJ,
and
Sessa WC.
Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in hypertension.
Am J Physiol Gastrointest Liver Physiol
277:
G463-G468,
1999
28.
Udelsman, R,
Blake MJ,
Stagg CA,
Ding-gang L,
Putney DJ,
and
Holbrook NJ.
Vascular heat shock protein expression in response to stress.
J Clin Invest
91:
465-473,
1993.
29.
Welsh, MJ,
Wu W,
Parvinen M,
and
Gilmont RR.
Variation in expression of hsp27 messenger ribonucleic acid during the cycle of the seminiferous epithelium and co-localization of hsp27 and microfilaments in sertoli cells of the rat.
Biol Reprod
55:
141-151,
1996[Abstract].
30.
Woodrum, D,
Brophy CM,
Wingard CJ,
Beall A,
and
Rasmussen H.
The phosphorylation events associated with cyclic nucleotide-dependent inhibition of smooth muscle contraciton.
Am J Physiol Heart Circ Physiol
277:
H931-H939,
1999
31.
Yeh, JL,
Whitney EG,
and
Brophy CM.
Nitric oxide is an autocrine feedback regulator of vascular smooth muscle contraction.
Surgery
119:
104-109,
1996[Web of Science][Medline].
This article has been cited by other articles:
![]() |
S. Somara, R. Gilmont, and K. N. Bitar Role of thin-filament regulatory proteins in relaxation of colonic smooth muscle contraction Am J Physiol Gastrointest Liver Physiol, November 1, 2009; 297(5): G958 - G966. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Knock, A. S. De Silva, V. A. Snetkov, R. Siow, G. D. Thomas, M. Shiraishi, M. P. Walsh, J. P. T. Ward, and P. I. Aaronson Modulation of PGF2{alpha}- and hypoxia-induced contraction of rat intrapulmonary artery by p38 MAPK inhibition: a nitric oxide-dependent mechanism Am J Physiol Lung Cell Mol Physiol, December 1, 2005; 289(6): L1039 - L1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Armstead and J. G. Hecker Heat shock protein modulation of KATP and KCa channel cerebrovasodilation after brain injury Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1184 - H1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ergul, V. Portik-Dobos, A. D. Giulumian, M. M. Molero, and L. C. Fuchs Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2225 - H2232. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Gerthoffer and S. J. Gunst Signal Transduction in Smooth Muscle: Invited Review: Focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle J Appl Physiol, August 1, 2001; 91(2): 963 - 972. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |